Rankings
▼
Calendar
EBS (Emergent BioSolutions Inc.) Stock Financials & Earnings | Market Cap Arena
EBS
Emergent BioSolutions Inc.
Mkt Cap
$446M
Healthcare
·
Drug Manufacturers - Specialty & Generic
·
🇺🇸 United States
·
NYSE
Revenue (TTM)
$743M
Net Income (TTM)
$53M
EPS (TTM)
$0.93
Free Cash Flow (TTM)
$157M
Gross Margin
48.6%
Op. Margin
16.4%
Net Margin
7.1%
FCF Margin
21.1%
P/S Ratio (TTM)
0.6x
P/E Ratio (TTM)
8.5x
YoY Rev Growth
-28.8%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$164M
-$24M
-$148M
Q2 23
$338M
$123M
-$293M
Q3 23
$271M
$92M
-$242M
Q4 23
$277M
$169M
-$44M
Q1 24
$300M
$141M
$40M
Q2 24
$255M
-$66M
-$204M
Q3 24
$294M
$164M
$65M
Q4 24
$195M
$137M
-$10M
Q1 25
$222M
$119M
$50M
Q2 25
$141M
$61M
$2M
Q3 25
$231M
$139M
$77M
Q4 25
$149M
$42M
-$6M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
0.5x
—
Q2 23
0.4x
—
Q3 23
0.4x
—
Q4 23
0.4x
—
Q1 24
0.4x
—
Q2 24
0.4x
—
Q3 24
0.4x
—
Q4 24
0.4x
—
Q1 25
0.5x
—
Q2 25
0.5x
3.2x
Q3 25
0.6x
5.9x
Q4 25
0.6x
8.5x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$184M
-$199M
Q2 23
-$114M
-$127M
Q3 23
$60M
$47M
Q4 23
$32M
$21M
Q1 24
-$63M
-$73M
Q2 24
$48M
$43M
Q3 24
$154M
$148M
Q4 24
-$80M
-$82M
Q1 25
-$11M
-$15M
Q2 25
$106M
$104M
Q3 25
-$2M
-$6M
Q4 25
$78M
$74M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$15M
Q2 23
$13M
Q3 23
$13M
Q4 23
$11M
Q1 24
$11M
Q2 24
$5M
Q3 24
$6M
Q4 24
$2M
Q1 25
$4M
Q2 25
$3M
Q3 25
$3M
Q4 25
$4M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-46.6%
+3.6%
Q2 23
+40.9%
+99.8%
Q3 23
+12.8%
+79.7%
Q4 23
-16.2%
-16.9%
Q1 24
+82.8%
-16.4%
Q2 24
-24.6%
-27.4%
Q3 24
+8.6%
-55.3%
Q4 24
-29.6%
-36.3%
Q1 25
-26.0%
-33.9%
Q2 25
-44.7%
-69.6%
Q3 25
-21.3%
-32.6%
Q4 25
-23.6%
-24.3%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$0
0.0%
Q2 23
$0
0.0%
Q3 23
$4M
1.5%
Q4 23
$4M
1.4%
Q1 24
$6M
2.0%
Q2 24
$6M
2.2%
Q3 24
$2M
0.8%
Q4 24
$4M
2.2%
Q1 25
$2M
0.7%
Q2 25
$5M
3.3%
Q3 25
$5M
2.1%
Q4 25
$5M
3.6%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$41M
$96M
Q2 23
$26M
$91M
Q3 23
$15M
$80M
Q4 23
$29M
$89M
Q1 24
$15M
$85M
Q2 24
$33M
$77M
Q3 24
$14M
$76M
Q4 24
$9M
$61M
Q1 25
$15M
$53M
Q2 25
$13M
$44M
Q3 25
$14M
$39M
Q4 25
$12M
$51M
marketcaparena.com
Revenue Segments
Contract Development And Manufacturing
Contracts and Grants
Product
Quarter
Contract Development And Manufacturing
Contracts and Grants
Product
Q1 23
$15M
$7M
$143M
Q2 23
$29M
$7M
$302M
Q3 23
$14M
$7M
$250M
Q4 23
$20M
$7M
$249M
Q1 24
$19M
$8M
$274M
Q2 24
$65M
$7M
$183M
Q3 24
$14M
$10M
$270M
Q4 24
$7M
$5M
$182M
Q1 25
—
$13M
$209M
Q2 25
—
$11M
$130M
Q3 25
—
$9M
$222M
Q4 25
—
$5M
$144M
marketcaparena.com
Revenue by Geography
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$430M
$0
$430M
Q2 23
$89M
$0
$89M
Q3 23
$88M
$0
$88M
Q4 23
$112M
$0
$112M
Q1 24
$79M
$0
$79M
Q2 24
$70M
$0
$70M
Q3 24
$150M
$0
$150M
Q4 24
$106M
$0
$106M
Q1 25
$149M
$0
$149M
Q2 25
$271M
$0
$271M
Q3 25
$246M
$0
$246M
Q4 25
$205M
$0
$205M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
50M
+0.6%
Q2 23
51M
+1.0%
Q3 23
52M
+2.2%
Q4 23
52M
+0.2%
Q1 24
52M
+0.6%
Q2 24
53M
+0.8%
Q3 24
56M
+5.7%
Q4 24
54M
-2.5%
Q1 25
57M
+5.7%
Q2 25
54M
-5.4%
Q3 25
57M
+4.2%
Q4 25
57M
+0.4%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$316K
1K
FY 15
$379K
1K
FY 16
$445K
1K
FY 17
$447K
1K
FY 18
$459K
2K
FY 19
$603K
2K
FY 20
$717K
2K
FY 21
$734K
2K
FY 22
$447K
3K
FY 23
$656K
2K
FY 24
$1M
900
FY 25
$4K
200K
marketcaparena.com